We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00004184
First Posted: September 16, 2004
Last Update Posted: April 12, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by:
University of Alabama at Birmingham
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2001
  Primary Completion Date: June 2001 (Final data collection date for primary outcome measure)